362
Participants
Start Date
September 5, 2023
Primary Completion Date
December 16, 2024
Study Completion Date
September 12, 2025
Delgocitinib
Topical administration
Vehicle cream
Topical administration
LEO Pharma Investigational Site, Beijing
LEO Pharma Investigational Site, Beijing
LEO Pharma Investigational Site, Beijing
LEO Pharma Investigational Site, Beijing
LEO Pharma Investigational Site, Shenyang
LEO Pharma Investigational Site, Changchun
LEO Pharma Investigational Site, Shanghai
LEO Pharma Investigational Site, Nanjing
LEO Pharma Investigational Site, Zhenjiang
LEO Pharma Investigational Site, Changzhou
LEO Pharma Investigational Site, Wuxi
LEO Pharma Investigational Site, Hefei
LEO Pharma Investigational Site, Hangzhou
LEO Pharma Investigational Site, Hangzhou
LEO Pharma Investigational Site, Hangzhou
LEO Pharma Investigational Site, Yiwu
LEO Pharma Investigational Site, Wenzhou
LEO Pharma Investigational Site, Nanchang
LEO Pharma Investigational Site, Fuzhou
LEO Pharma Investigational Site, Changsha
LEO Pharma Investigational Site, Changsha
LEO Pharma Investigational Site, Wuhan
LEO Pharma Investigational Site, Wuhan
LEO Pharma Investigational Site, Wuhan
LEO Pharma Investigational Site, Nanyang
LEO Pharma Investigational Site, Guangzhou
LEO Pharma Investigational Site, Guangzhou
LEO Pharma Investigational Site, Shenzhen
LEO Pharma Investigational Site, Shenzhen
LEO Pharma Investigational Site, Shenzhen
LEO Pharma Investigational Site, Shenzhen
LEO Pharma Investigational Site, Guiyang
LEO Pharma Investigational Site, Chengdu
LEO Pharma Investigational Site, Chengdu
LEO Pharma Investigational Site, Xianyang
LEO Pharma Investigational Site, Yinchuan
LEO Pharma Investigational Site, Shijiazhuang
Lead Sponsor
LEO Pharma
INDUSTRY